We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAAS icon
226
Pan American Silver
PAAS
$21.6B
$1.48M 0.12%
38,106
-5,845
-13% -$188K
CNNE icon
227
Cannae Holdings
CNNE
$649M
$1.47M 0.11%
80,037
+37
+0% +$731
CVNA icon
228
Carvana
CVNA
$77.9B
$1.46M 0.11%
19,300
+8,360
+76% +$598K
SIMO icon
229
Silicon Motion
SIMO
$8.68B
$1.44M 0.11%
15,160
+7,447
+97% +$592K
FICO icon
230
Fair Isaac
FICO
$22.5B
$1.44M 0.11%
+960
New +$1.44M
TGT icon
231
Target
TGT
$68B
$1.43M 0.11%
15,950
+10,418
+188% +$1.03M
BYD icon
232
Boyd Gaming
BYD
$6.06B
$1.42M 0.11%
16,453
-15
-0.1% -$1.26K
JD icon
233
JD.com
JD
$44.5B
$1.41M 0.11%
40,403
+403
+1% +$13.1K
EQX icon
234
Equinox Gold
EQX
$13.5B
$1.4M 0.11%
125,017
-62,188
-33% -$495K
APH icon
235
Amphenol
APH
$209B
$1.4M 0.11%
11,301
-13,466
-54% -$1.48M
CRM icon
236
Salesforce
CRM
$158B
$1.39M 0.11%
+5,860
New +$1.48M
T icon
237
AT&T
T
$163B
$1.38M 0.11%
48,969
+13,489
+38% +$383K
ZK
238
DELISTED
Zeekr
ZK
$1.37M 0.11%
+45,000
New +$1.3M
ETNB
239
DELISTED
89bio
ETNB
$1.37M 0.11%
92,955
+22,568
+32% +$230K
ULTY icon
240
YieldMax Ultra Option Income Strategy ETF
ULTY
$764M
$1.36M 0.11%
+24,920
New +$1.48M
VERA icon
241
Vera Therapeutics
VERA
$2.36B
$1.35M 0.11%
46,551
+20,951
+82% +$485K
PLYM
242
DELISTED
Plymouth Industrial REIT
PLYM
$1.34M 0.1%
+60,122
New +$1.1M
CZR icon
243
Caesars Entertainment
CZR
$6.14B
$1.34M 0.1%
49,564
-34,582
-41% -$937K
SGRY icon
244
Surgery Partners
SGRY
$2.03B
$1.32M 0.1%
61,205
-2,734
-4% -$61K
EIDO icon
245
iShares MSCI Indonesia ETF
EIDO
$501M
$1.32M 0.1%
75,000
PZA icon
246
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.26B
$1.31M 0.1%
+56,750
New +$1.27M
TDOC icon
247
Teladoc Health
TDOC
$1.3B
$1.31M 0.1%
169,489
+156,547
+1,210% +$1.22M
DIS icon
248
Walt Disney
DIS
$181B
$1.31M 0.1%
+11,425
New +$1.35M
TRML
249
DELISTED
Tourmaline Bio
TRML
$1.3M 0.1%
+27,282
New +$757K
CVS icon
250
CVS Health
CVS
$122B
$1.3M 0.1%
17,289
+13,609
+370% +$933K

Similar funds

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.